The DKFZ
Business Services · Germany · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Im Neuenheimer Feld 280, Heidelberg, Bad...Phone Number
+49 496221420Website
www.dkfz.deRevenue
$321.3 MillionIndustry
About The DKFZ
The DKFZ Org Chart
Is The DKFZ your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once The DKFZ has new funding data
The DKFZ, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when The DKFZ launches new products
Click to see if The DKFZ had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at The DKFZ
Website visits: Recent activity has been detected on your website
Check out if The DKFZ is spiking on competitors!
Check if The DKFZ has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on The DKFZ recently announced quarterly report
Recommended Actions
Find VP level buyers at The DKFZ
Find 2 more new buyers
Company Profile Activity
Activity Insights
The DKFZ is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
The DKFZ is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about The DKFZ.
The DKFZ Tech Stack
A closer look at the technologies used by The DKFZ
Most Recent Scoops
The DKFZ News & Media
Breakthrough in Personalized Brain Tumor Therapy: Scientists Develop Patient-Specific ...
An innovative model mimics brain tumor structures, enabling precise drug testing and advancing personalized cancer therapy.The German Cancer Research Center Enhances Data Management and Security with Datadobi
LEUVEN, Belgium--(BUSINESS WIRE)--DKFZ Leverages StorageMAP Platform to Manage Unstructured Data and Provide Protection, and Datadobi Announces Launch of StorageMAP 6.5Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a collaboration with the German Cancer Research Center (DKFZ), to develop and discover Bicycle® radio conjugates (BRCs) for a range of oncology targets. Founded in 1964, DKFZ is the largest biomedical research institution iTelix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option Agreement for Image-Guided Prostate Surgery
MELBOURNE, Australia and HEIDELBERG, Germany, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR) has today announced that it has entered into a collaboration agreement with the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) in the fiel
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The DKFZ
The Deutsches Krebsforschungszentrum (DKFZ) is Germany's largest biomedical research institution dedicated to cancer research, aiming to reduce cancer incidence and improve treatment outcomes. It focuses on various research areas including cell and tumor biology, genomics, cancer risk factors, immunology, and imaging. The center collaborates nation... Read More